Sufficient vitamin D levels may positively influence the outcome of COVID-19 infection, especially in hospitalized patients.
Low vitamin D levels are linked to various autoimmune, cardiovascular, and infectious diseases. Vitamin D plays a vital role in promoting immune response and could protect against COVID-19. In a study published in the journal PLOS ONE researchers from the Azrieli Faculty of Medicine of Bar-Ilan University in Safed, Israel and the Galilee Medical Center in Nahariya, Israel, show a correlation between vitamin D deficiency and COVID-19 severity and mortality.
‘Patient's history of vitamin D deficiency is a predictive risk factor linked to poorer COVID-19 clinical disease course and mortality.’
Read More..
The study is the first to analyze vitamin D levels before infection, which facilitates a more accurate assessment than during hospitalization, when levels may be lower secondary to the viral illness.Read More..
Researchers searched the records of 1,176 patients admitted between April 2020 and February 2021 to the Galilee Medical Center (GMC) with positive PCR tests for vitamin D levels measured two weeks to two years before infection.
Patients with vitamin D deficiency (less than 20 ng/mL) were 14 times more likely to have severe or critical cases of COVID than those with more than 40 ng/mL.
Strikingly, mortality among patients with sufficient vitamin D levels was 2.3%, in contrast to 25.6% in the vitamin D deficient group.
The study adjusted for age, gender, season (summer/winter), chronic diseases and found similar results across the board highlighting that low vitamin D level contributes significantly to disease severity and mortality.
Advertisement
"There is a clear consensus for vitamin D supplementation regularly as advised by local health authorities as well as global health organizations."
Advertisement
"This study contributes to a continually evolving body of evidence suggesting that a patient’s history of vitamin D deficiency is a predictive risk factor associated with poorer COVID-19 clinical disease course and mortality," said study co-author Prof. Michael Edelstein, of the Azrieli Faculty of Medicine of Bar-Ilan University.
"It is still unclear why certain individuals suffer severe consequences of COVID-19 infection while others don’t. Our finding adds a new dimension to solving this puzzle."
Source-Medindia